MOF‐Based Single‐Atom and Metal Cluster Catalysts by Room‐Temperature Synthesis for Tumor Therapy
Advanced Healthcare Materials · 2025-07 · 14 (18)
DOI: 10.1002/adhm.202501058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.05.2025. Verfasst von Subin Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Basic Science Research Program, Korea Basic Science Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Metal–organic frameworks (MOFs) are widely used as substrates for creating single‐atom catalysts due to their abundance of ligands, facilitating enzyme‐like activity for biomedical applications. However, the high‐temperature calcination process for single‐atom catalysts limits economical, efficient, and large‐scale synthesis. Here, a simple room‐temperature synthesis of MOF‐based single‐atom and metal cluster catalysts is presented for tumor therapy. Fe/MOF is obtained through a coordination reaction at room temperature, while Au/MOF is synthesized from Au 3+ /MOF by introducing a reducing agent. Au/MOF effectively generates hydrogen peroxide (H 2 O 2 ) from glucose, outperforming Au 3+ /MOF, and Fe/MOF subsequently produced hydroxyl radicals (•OH) by decomposing the generated H 2 O 2 via accelerated peroxidase‐like activity in an acidic environment. In vitro and in vivo studies confirm a significantly enhanced cancer eradication ability compared to the PBS‐treated group by combining cascade enzymatic activity, destruction of oxidative homeostasis, and excessive mitochondrial‐mediated lipid peroxidation. The novel synthesis process of MOF‐based metal single‐atom catalysts establishes a new paradigm for fabricating effective enzyme‐like nanomaterials for multimodal tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.
- Harvard Institute of Medicine, Harvard Medical School, Harvard University, Brigham and Women's Hospital, Boston, MA, 02115, USA.
- Department of Chemical and Biological Engineering, Sookmyung Women's University, Seoul, 04310, Republic of Korea.
- Department of Biomicrosystem Technology, Korea University, Seoul, 02841, Republic of Korea.
- Chemical and Biological Integrative Research Center, Korea Institute of Science and Technology, 5, Hwarang-ro 14-gil, Seongbuk-gu, Seoul, 02792, Republic of Korea.
- Department of Chemistry, National Taiwan University, Taipei, 106, Taiwan.
ORCID-Profile: Subin Yu, Luke P Lee
Förderung
- Basic Science Research Program
- Korea Basic Science Institute
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Yu, S., Kang, H., Jee, S., Moon, W., Jang, D., Huang, W. T., Kim, D., Chung, K., Won, D. I., Park, J., Liu, R. S., Choi, K., Kim, S., Lee, L. P., & Kim, D. H. (2025). MOF‐Based Single‐Atom and Metal Cluster Catalysts by Room‐Temperature Synthesis for Tumor Therapy. Advanced Healthcare Materials, 14(18). https://doi.org/10.1002/adhm.202501058
Vancouver
Yu S, Kang H, Jee S, Moon W, Jang D, Huang WT, et al. MOF‐Based Single‐Atom and Metal Cluster Catalysts by Room‐Temperature Synthesis for Tumor Therapy. Advanced Healthcare Materials. 2025;14(18). doi:10.1002/adhm.202501058
BibTeX
@article{Yu2025,
author = {Yu, Subin and Kang, Haeun and Jee, Seohyeon and Moon, WooYeon and Jang, Dohyub and Huang, Wen-Tse and Kim, Dongjun and Chung, Kyungwha and Won, Dong-Il and Park, Jungwon and Liu, Ru-Shi and Choi, Kyungmin and Kim, Sehoon and Lee, Luke P and Kim, Dong Ha},
title = {MOF‐Based Single‐Atom and Metal Cluster Catalysts by Room‐Temperature Synthesis for Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {18},
doi = {10.1002/adhm.202501058}
}
EUVIMED